The bank quantified the impact on individual stocks of the Iran war using a scoring system. Some companies stand to be ceasefire winners.
Buy these ‘income darlings’ to boost your portfolio, says Jefferies
Stocks such as Target and CVS Health could help steady portfolios in the current period of geopolitical volatility, Jefferies said.
Morgan Stanley sees these stocks rewarding investors this earnings season based on at least one key indicator each
Topping expectations in at least one key performance indicator could drive up shares of Datadog, Draftkings and others, according to Morgan Stanley.
This software giant is due for a big catch-up trade as stock market rallies. How to trade with options
Nishant Pant breaks down this bull call spread.
This social media stock has struggled this year. Why one analyst says it’s time to buy
The investment firm assigned a buy rating to the social media name.
Why the timing of Apple’s CEO change could mean a good earnings report is around the corner
Analysts like that announcement comes prior to second-quarter earnings
Here are Tuesday’s biggest analyst calls: Nvidia, Apple, Tesla, Intel, Reddit, CrowdStrike, Disney, Palo Alto & more
Here are Tuesday’s biggest calls on Wall Street.
This biotech firm has room to run despite surging nearly 500% in past year, Morgan Stanley says
The investment bank upgraded the pharma stock to overweight from equal weight.
This cybersecurity stock has room to run following Claude Mythos Preview’s release, KeyBanc says
CrowdStrike is likely to see its shares rise as Mythos’ limited roll out acts as a catalyst for cybersecurity spending, according to Key Banc.
Apple goes for the ‘continuity candidate’ to replace Cook. What the CEO change means for investors
Apple’s surprise leadership announcement sent Wall Street reconsidering their expectations for the future of the technology titan.